Trial intelligence / Profile preview

PRP vs Hyaluronic Acid for Genitourinary Syndrome of Menopause

NCT05571527Recruiting

Sponsor
Kanuni Sultan Süleyman Training and Research Hospital
Start
Nov 2023
Primary completion
Mar 2024
Modality
Adipose-derived MSCs, Bone Marrow MSCs
Countries
1
01

Overview

Open-label trial of platelet-rich plasma in genitourinary syndrome of menopause (GSM) (2 arms), sponsored by Kanuni Sultan Süleyman Training and Research Hospital. Primary endpoints: Vaginal Health Index Score, Vulvovaginal Symptom Questionnaire and 3 more. Started Nov 2023; status: recruiting.

02

Drugs

platelet-rich plasma
03

Conditions

genitourinary syndrome of menopause (GSM)

Beyond the preview

Go deeper on NCT05571527.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05571527.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call